Constant domains influence binding of mouse–human chimeric antibodies to the capsular polypeptide of Bacillus anthracis

References

• Inglesby TV, O’Toole T, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, et al, Working Group on Civilian Biodefense. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 2002; 287:2236 - 52; http://dx.doi.org/10.1001/jama.287.17.2236; PMID: 11980524
   PubMed Web of Science ®Google Scholar
• Sweeney DA, Hicks CW, Cui X, Li Y, Eichacker PQ. Anthrax infection. Am J Respir Crit Care Med 2011; 184:1333 - 41; http://dx.doi.org/10.1164/rccm.201102-0209CI; PMID: 21852539
   PubMed Web of Science ®Google Scholar
• Kaspar RL, Robertson DL. Purification and physical analysis of Bacillus anthracis plasmids pXO1 and pXO2. Biochem Biophys Res Commun 1987; 149:362 - 8; http://dx.doi.org/10.1016/0006-291X(87)90375-5; PMID: 3122734
   PubMed Web of Science ®Google Scholar
• Makino S, Uchida I, Terakado N, Sasakawa C, Yoshikawa M. Molecular characterization and protein analysis of the cap region, which is essential for encapsulation in Bacillus anthracis. J Bacteriol 1989; 171:722 - 30; PMID: 2536679
   PubMed Web of Science ®Google Scholar
• Candela T, Fouet A. Bacillus anthracis CapD, belonging to the gamma-glutamyltranspeptidase family, is required for the covalent anchoring of capsule to peptidoglycan. Mol Microbiol 2005; 57:717 - 26; http://dx.doi.org/10.1111/j.1365-2958.2005.04718.x; PMID: 16045616
   PubMed Web of Science ®Google Scholar
• Hanby WE, Rydon HN. The capsular substance of Bacillus anthracis.. Biochem J 1946; 40:297 - 309; PMID: 20989452
   PubMed Web of Science ®Google Scholar
• Zwartouw HT, Smith H. Polyglutamic acid from Bacillus anthracis grown in vivo; structure and aggressin activity. Biochem J 1956; 63:437 - 42; PMID: 13341899
   PubMed Web of Science ®Google Scholar
• Wang TT, Lucas AH. The capsule of Bacillus anthracis behaves as a thymus-independent type 2 antigen. Infect Immun 2004; 72:5460 - 3; http://dx.doi.org/10.1128/IAI.72.9.5460-5463.2004; PMID: 15322045
   PubMed Web of Science ®Google Scholar
• Drysdale M, Heninger S, Hutt J, Chen Y, Lyons CR, Koehler TM. Capsule synthesis by Bacillus anthracis is required for dissemination in murine inhalation anthrax. EMBO J 2005; 24:221 - 7; http://dx.doi.org/10.1038/sj.emboj.7600495; PMID: 15616593
   PubMed Web of Science ®Google Scholar
• Chabot DJ, Scorpio A, Tobery SA, Little SF, Norris SL, Friedlander AM. Anthrax capsule vaccine protects against experimental infection. Vaccine 2004; 23:43 - 7; http://dx.doi.org/10.1016/j.vaccine.2004.05.029; PMID: 15519706
   PubMed Web of Science ®Google Scholar
• Kozel TR, Thorkildson P, Brandt S, Welch WH, Lovchik JA, AuCoin DP, et al. Protective and immunochemical activities of monoclonal antibodies reactive with the Bacillus anthracis polypeptide capsule. Infect Immun 2007; 75:152 - 63; http://dx.doi.org/10.1128/IAI.01133-06; PMID: 17060470
   PubMed Web of Science ®Google Scholar
• Chen Z, Schneerson R, Lovchik J, Lyons CR, Zhao H, Dai Z, et al. Pre- and postexposure protection against virulent anthrax infection in mice by humanized monoclonal antibodies to Bacillus anthracis capsule. Proc Natl Acad Sci U S A 2011; 108:739 - 44; http://dx.doi.org/10.1073/pnas.1017677108; PMID: 21187383
   PubMed Web of Science ®Google Scholar
• Sanford JE, Lupan DM, Schlageter AM, Kozel TR. Passive immunization against Cryptococcus neoformans with an isotype-switch family of monoclonal antibodies reactive with cryptococcal polysaccharide. Infect Immun 1990; 58:1919 - 23; PMID: 2341184
   PubMed Web of Science ®Google Scholar
• Hovenden M, Hubbard MA, Aucoin DP, Thorkildson P, Reed DE, Welch WH, et al. IgG subclass and heavy chain domains contribute to binding and protection by mAbs to the poly γ-D-glutamic acid capsular antigen of Bacillus anthracis. PLoS Pathog 2013; 9:e1003306; http://dx.doi.org/10.1371/journal.ppat.1003306; PMID: 23637599
   PubMed Web of Science ®Google Scholar
• Hornick CL, Karuch F. Antibody affinity. 3. The role of multivalance. Immunochemistry 1972; 9:325 - 40; http://dx.doi.org/10.1016/0019-2791(72)90096-1; PMID: 4556115
   PubMedGoogle Scholar
• Hubbard MA, Thorkildson P, Welch WH, Kozel TR. Stereo-selective binding of monoclonal antibodies to the poly-gamma-D-glutamic acid capsular antigen of Bacillus anthracis. Mol Immunol 2013; 55:337 - 44; http://dx.doi.org/10.1016/j.molimm.2013.03.010; PMID: 23602451
   PubMed Web of Science ®Google Scholar
• Richard RB, Schasfoort BM, Tudos AJ. Handbook of surface plasmon resonance. Royal Society of Chemistry. 2008; 134-135.
   Google Scholar
• MacGill TC, MacGill RS, Casadevall A, Kozel TR. Biological correlates of capsular (quellung) reactions of Cryptococcus neoformans.. J Immunol 2000; 164:4835 - 42; PMID: 10779792
   PubMed Web of Science ®Google Scholar
• Persson MA, Brown SE, Steward MW, Hammarström L, Smith CI, Howard CR, et al. IgG subclass-associated affinity differences of specific antibodies in humans. J Immunol 1988; 140:3875 - 9; PMID: 3131419
   PubMed Web of Science ®Google Scholar
• Devey ME, Bleasdale-Barr KM, Bird P, Amlot PL. Antibodies of different human IgG subclasses show distinct patterns of affinity maturation after immunization with keyhole limpet haemocyanin. Immunology 1990; 70:168 - 74; PMID: 2373517
   PubMed Web of Science ®Google Scholar
• Devey ME, Bleasdale KM, French MA, Harrison G. The IgG4 subclass is associated with a low affinity antibody response to tetanus toxoid in man. Immunology 1985; 55:565 - 7; PMID: 4018840
   PubMed Web of Science ®Google Scholar
• Devey ME, Lee SR, Le Page S, Feldman R, Isenberg DA. Serial studies of the IgG subclass and functional affinity of DNA antibodies in systemic lupus erythematosus. J Autoimmun 1988; 1:483 - 94; http://dx.doi.org/10.1016/0896-8411(88)90069-8; PMID: 3075912
   PubMed Web of Science ®Google Scholar
• Torres M, Fernandez-Fuentes N, Fiser A, Casadevall A. Exchanging murine and human immunoglobulin constant chains affects the kinetics and thermodynamics of antigen binding and chimeric antibody autoreactivity. PLoS One 2007; 2:e1310; http://dx.doi.org/10.1371/journal.pone.0001310; PMID: 18074033
   PubMed Web of Science ®Google Scholar
• Beenhouwer DO, Yoo EM, Lai CW, Rocha MA, Morrison SL. Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection. Infect Immun 2007; 75:1424 - 35; http://dx.doi.org/10.1128/IAI.01161-06; PMID: 17220317
   PubMed Web of Science ®Google Scholar
• Sagawa T, Oda M, Morii H, Takizawa H, Kozono H, Azuma T. Conformational changes in the antibody constant domains upon hapten-binding. Mol Immunol 2005; 42:9 - 18; http://dx.doi.org/10.1016/j.molimm.2004.07.004; PMID: 15488939
   PubMed Web of Science ®Google Scholar
• McCloskey N, Turner MW, Steffner P, Owens R, Goldblatt D. Human constant regions influence the antibody binding characteristics of mouse-human chimeric IgG subclasses. Immunology 1996; 88:169 - 73; http://dx.doi.org/10.1111/j.1365-2567.1996.tb00001.x; PMID: 8690447
   PubMed Web of Science ®Google Scholar
• Morelock MM, Rothlein R, Bright SM, Robinson MK, Graham ET, Sabo JP, et al. Isotype choice for chimeric antibodies affects binding properties. J Biol Chem 1994; 269:13048 - 55; PMID: 7909805
   PubMed Web of Science ®Google Scholar
• Dangl JL, Wensel TG, Morrison SL, Stryer L, Herzenberg LA, Oi VT. Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. EMBO J 1988; 7:1989 - 94; PMID: 3138110
   PubMed Web of Science ®Google Scholar